Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
47.84
-0.88 (-1.81%)
Feb 21, 2025, 4:00 PM EST - Market closed
Tarsus Pharmaceuticals Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$56.00
Upside
+17.06%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Feb 10, 2025 |
| Barclays | Barclays | Buy Maintains $60 → $62 | Buy | Maintains | $60 → $62 | +29.60% | Jan 27, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $65 → $72 | Buy | Maintains | $65 → $72 | +50.50% | Jan 22, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 → $41 | Hold | Maintains | $36 → $41 | -14.30% | Nov 15, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $63 → $65 | Buy | Maintains | $63 → $65 | +35.87% | Nov 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $61 → $63 | Buy | Reiterates | $61 → $63 | +31.69% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $61 | Strong Buy | Maintains | $57 → $61 | +27.51% | May 13, 2024 |
| Barclays | Barclays | Buy Maintains $50 → $60 | Buy | Maintains | $50 → $60 | +25.42% | May 10, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $59 → $61 | Buy | Maintains | $59 → $61 | +27.51% | May 9, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $30 → $44 | Strong Buy | Maintains | $30 → $44 | -8.03% | Mar 6, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $19 → $30 | Hold | Maintains | $19 → $30 | -37.29% | Feb 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $57 | Strong Buy | Maintains | $50 → $57 | +19.15% | Feb 28, 2024 |
| Barclays | Barclays | Buy Maintains $40 → $50 | Buy | Maintains | $40 → $50 | +4.52% | Feb 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $55 → $59 | Buy | Reiterates | $55 → $59 | +23.33% | Feb 28, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $19 | Hold | Initiates | $19 | -60.28% | Nov 20, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $50 | Strong Buy | Maintains | $42 → $50 | +4.52% | Nov 10, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.